Shoulder Innovations Q2 Earnings Call Highlights

Impact · against what's priced in

Shoulder Innovations shows strong commercial momentum with a 56% revenue jump and an upgraded full-year outlook, signaling successful market share gains against incumbents. Improving gross margins and a narrowing net loss suggest the company is scaling efficiently toward profitability.

SI+0.60

No priced-in read yet

In context

The company raised its 2026 revenue outlook to $67-$69 million and reported 56% year-over-year growth in Q2 revenue to $17.2 million, driven by expanding surgeon adoption and market share gains.

Read from the article alone

• guidance
• revenue growth
• earnings
• healthcare
• SI
• fda
• medical devices
• orthopedics
• robotics

Search tags